Replies to post #1186 on Cocrystal Pharma Inc (COCP)

[dividendsplus]

Well they have a poster on CC-31244. That particular compound appears promising through Phase 1a and now 1b. Also we have Schinazi exercising options, albeit only at 4.7 cents per share.